McKesson | MCK - Cost Of Sales


McKesson reported $92.25B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Acadia Healthcare USD 30.76M 349K Dec/2025
Align Technology USD 303.5M 60.47M Mar/2026
Cardinal Health USD 58.54B 4.82B Mar/2026
Centene USD 44.39B 3.2B Mar/2026
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Cigna USD 62.41B 4.1B Mar/2026
Community Health Systems USD 555M 13M Dec/2025
Computer Programs Systems USD 52.17M 9.8M Dec/2025
CVS Health USD 84.8B 7.32B Mar/2026
DaVita Healthcare Partners USD 2.52B 76.13M Mar/2026
Dentsply International USD 453M 65M Mar/2026
eHealth USD 58.41M 7.45M Sep/2024
Elevance Health USD 38.07B 75M Dec/2025
Encompass Health USD 151.6M 700K Mar/2026
HCA USD 3.78B 105M Mar/2026
Henry Schein USD 2.3B 145M Mar/2026
Humana USD 26.54B 1.15B Mar/2025
IQVIA Holdings USD 3.08B 161M Mar/2026
J&J USD 8.07B 103M Mar/2026
Laboratory Of America USD 2.6B 4.2M Mar/2026
McKesson USD 92.25B 10.22B Mar/2026
Molina Healthcare USD 9.77B 406M Mar/2026
Owens Minor USD 436.92M 32.62M Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Tenet Healthcare USD 1.19B 51M Mar/2026
UnitedHealth USD 94.72B 2.2B Dec/2025
Universal Health Services USD 422.76M 2.06B Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022